Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

Blood (2016) 128 (22): 151.

https://doi.org/10.1182/blood.V128.22.151.151

Published: 2016

Journal Articles

In MDS Targeted Deep Sequencing of CD34 + Blood Cells but Not Peripheral Blood Mononuclear Cells Give Results Which Are Representative for Bone Marrow

Roman Martin, PhD, Laura Palomo, MSc, Christina Ganster, PhD, Pamela Acha, Sascha Dierks, PhD, Mar Mallo, PhD, Vera Adema, Francisco Fuster-Tormo, MSc, Paula Gomez-Marzo, MSc, Nuria De Haro, Neus Solanes, Lurdes Zamora, PhD, Blanca Xicoy, MD, Arkadiusz Kominowski, Martin Stromburg, Alina Brockmann, Lorenz H. Truemper, MD PhD, Francesc Sole, PhD, Detlef Haase, MD

Blood (2016) 128 (22): 2383.

https://doi.org/10.1182/blood.V128.22.2383.2383

Published: 2016

Journal Articles

Obesity Is a Prognostic Factor in Elderly Female Patients with Aggressive B-Cell Lymphomas Treated with R- CHOP

Karin Hohloch, PD Dr., Bettina Altmann, Michael Pfreundschuh, MD, Markus Loeffler, Prof., Norbert Schmitz, MD, Marita Ziepert, PhD, Lorenz H. Truemper, MD PhD

Blood (2015) 126 (23): 1509.

https://doi.org/10.1182/blood.V126.23.1509.1509

Published: 2015

Journal Articles

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

Blood (2015) 126 (23): 3875.

https://doi.org/10.1182/blood.V126.23.3875.3875

Published: 2015

Journal Articles

Liposomal Formulation of Vincristine Allows for Doubling the Dose Compared to Conventional Vincristine: Results of the First Futility Analysis of the OPTIMAL>60 Study of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

Sascha Duecker, Viola Poeschel, Anne Wolf, MD, Gerhard Held, MD, Niels Murawski, MD, Carsten Zwick, MD, Mathias Haenel, MD, Andreas Viardot, Lorenz H. Truemper, MD PhD, Marita Ziepert, Michael Pfreundschuh

Blood (2014) 124 (21): 4420.

https://doi.org/10.1182/blood.V124.21.4420.4420

Published: 2014

Journal Articles

Combination of Lenalidomide and R-DHAP for Treatment of Relapsed and Refractory Aggressive B-NHL

Bertram Glass, MD, Anke Goerlitz, Sebastian Pfeiffer, Maike Nickelsen, MD, Andreas Huettmann, MD, Justin Hasenkamp, MD, Lorenz H. Truemper, MD PhD, Martin Dreyling, Michael G Kiehl, MD, Hans Salwender, MD, Norbert Schmitz, MD

Blood (2014) 124 (21): 1754.

https://doi.org/10.1182/blood.V124.21.1754.1754

Published: 2014

Journal Articles

Minimum Tolerable Interval of Radioimmunotherapy and Autologous Stem Cell Transplantation after High-Dose Chemotherapy for Relapsed or Refractory Aggressive B Cell Non-Hodgkin-Lymphoma Provides Excellent Disease Control

Justin Hasenkamp, MD, Georg Hess, MD, Bernd Hertenstein, MD, Mathias Witzens-Harig, MD, Lutz Uharek, MD, Martin Gramatzki, MD, Michael Pfreundschuh, Gerald Wulf, MD, Lorenz H. Truemper, MD PhD, Norbert Schmitz, MD, Bertram Glass, MD

Blood (2014) 124 (21): 3986.

https://doi.org/10.1182/blood.V124.21.3986.3986

Published: 2014

Journal Articles

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Martin H. Dreyling, MD, Eva Hoster, PhD, Achiel Van Hoof, Bernd Metzner, Christian Gisselbrecht, Michael Pfreundschuh, MD, PhD, Marcel Reiser, Lorenz H. Truemper, MD, PhD, Hjalmar Steinhauer, Jean-Michel Boiron, MD, PhD, Marc Boogaerts, MD, PhD, Vittorio Silingardi, J.C. Kluin- Nelemans, MD, PhD, Michael Unterhalt, Wolfgang Hiddemann

Blood (2008) 112 (11): 769.

https://doi.org/10.1182/blood.V112.11.769.769

Published: 2008

Journal Articles

Bortezomib, Intravenous Cyclophosphamide and Dexamethasone (VelCD) for Previously Untreated Multiple Myeloma: An Interim Analysis of the German DSMM XIa Trial

Blood (2008) 112 (11): 2776.

https://doi.org/10.1182/blood.V112.11.2776.2776

Published: 2008

Journal Articles

Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS

Julia Hartmann, Ursula Sinzig, Gerald Wulf, MD, PhD, Lorenz H. Truemper, MD, PhD, Friederike Braulke, MD, Frank Konietschke, Detlef Haase, MD, PhD

Blood (2008) 112 (11): 2694.

https://doi.org/10.1182/blood.V112.11.2694.2694

Published: 2008

Journal Articles

Analysing Circulating CD34+ Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities

Friederike Braulke, MD, Julie Schanz, MD, Lorenz H. Truemper, MD, PhD, Detlef Haase, MD, PhD

Blood (2008) 112 (11): 2696.

https://doi.org/10.1182/blood.V112.11.2696.2696

Published: 2008

Journal Articles

CHOP Improves Response Rates but Not Overall Survival in Follicular and Mantle Cell Lymphoma (MCL)- Results of a Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG ).

Christina Nickenig, MD, Martin H. Dreyling, MD, PhD, Eva Schiegnitz, MSc, Michael Pfreundschuh, MD, PhD, Lorenz H. Truemper, MD, PhD, Marcel Reiser, MD, Hannes Wandt, MD, PhD, Eva Lengfelder, MD, PhD, Wolf-Dieter Ludwig, MD, PhD, Wolfgang E. Berdel, MD, PhD, Bernd Metzner, MD, Georg Hess, MD, Roswitha Forstpointner, MD, Reza Parwaresch, MD, PhD, Joerg Hasford, MD, PhD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD, PhD

Blood (2004) 104 (11): 611.

https://doi.org/10.1182/blood.V104.11.611.611

Published: 2004

Journal Articles

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free Survival in Mantle Cell Lymphoma - Long Term Follow up of a Prospective Randomized Trial of the European MCL Network .

Martin H. Dreyling, MD, PhD, Georg Lenz, MD, Eva Schiegnitz, MSc, Achiel van Hoof, MD, Christian Gisselbrecht, MD, PhD, Michael Pfreundschuh, MD, PhD, Bernd Metzner, MD, Lorenz H. Truemper, MD, PhD, Marcel Reiser, MD, Hjalmar B. Steinhauer, MD, PhD, Jean-Michel Boiron, MD, PhD, Marc A. Boogaerts, MD, PhD, Ali Aldaoud, MD, Vittorio Silingardi, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Joerg Hasford, MD, PhD, Reza Parwaresch, MD, PhD, Unterhalt Michael, MD, PhD, Hiddemann Wolfgang, MD, PhD

Blood (2004) 104 (11): 7.

https://doi.org/10.1182/blood.V104.11.7.7

Published: 2004

Journal Articles

Sequential Cytogenetic Analysis of 322 Patients with Myelodysplastic Syndromes. Delineation of Genetic Evolution and Clinical Implications.

Christian Steidl, MD, Rainer Schabla, Ulrich Germing, MD, PhD, Barbara Hildebrandt, MD, Thomas Noesslinger, MD, Michael Pfeilstocker, MD, PhD, Peter Haas, MD, Michael Lübbert, MD, PhD, Lorenz H. Truemper, MD, PhD, Detlef Haase, MD, PhD

Blood (2004) 104 (11): 2368.

https://doi.org/10.1182/blood.V104.11.2368.2368

Published: 2004

Journal Articles

R399H Mutated ETS Domain Leads to a Functional ETV6 Double-Knock-Out in Acute Leukemia and Completely Alters the Physiological Function of ETV6.

Heike Hennig, PhD, Frauke Hillmer, Annegret Becker, Martina Podleschny, Tobias Pukrop, MD, Lorenz H. Truemper, MD PhD, Frank Griesinger, MD PhD

Blood (2004) 104 (11): 2055.

https://doi.org/10.1182/blood.V104.11.2055.2055

Published: 2004

Journal Articles

Combined Immuno-Chemotherapy (R-CHOP) Results in Significantly Superior Response Rates and Time to Treatment Failure in First Line Treatment of Patients with Lymphomplasmocytoid/ic Immunocytoma (LP-IC) - Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG).

Christian Buske, MD, PhD, Martin H. Dreyling, MD, PhD, Hartmut Eimermacher, MD, Hans-Peter Boeck, MD, Michael Pfreundschuh, MD, PhD, Bernd Metzner, MD, Roland Fuchs, MD, PhD, Bernhard Woermann, MD, PhD, Lorenz H. Truemper, MD, PhD, Georg Hess, MD, Hannes Wandt, MD, PhD, Wolf-Dieter Ludwig, MD, PhD, Ernst-Dietrich Kreuser, MD, PhD, Joerg Schimke, MD, H.-J. Weh, MD, PhD, Stephan Schmitz, MD, PhD, W. Schmiegel, MD, PhD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD, PhD

Blood (2004) 104 (11): 162.

https://doi.org/10.1182/blood.V104.11.162.162

Published: 2004

NARROW

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

In MDS Targeted Deep Sequencing of CD34 + Blood Cells but Not Peripheral Blood Mononuclear Cells Give Results Which Are Representative for Bone Marrow

Obesity Is a Prognostic Factor in Elderly Female Patients with Aggressive B-Cell Lymphomas Treated with R- CHOP

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

Liposomal Formulation of Vincristine Allows for Doubling the Dose Compared to Conventional Vincristine: Results of the First Futility Analysis of the OPTIMAL>60 Study of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

Combination of Lenalidomide and R-DHAP for Treatment of Relapsed and Refractory Aggressive B-NHL

Minimum Tolerable Interval of Radioimmunotherapy and Autologous Stem Cell Transplantation after High-Dose Chemotherapy for Relapsed or Refractory Aggressive B Cell Non-Hodgkin-Lymphoma Provides Excellent Disease Control

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Bortezomib, Intravenous Cyclophosphamide and Dexamethasone (VelCD) for Previously Untreated Multiple Myeloma: An Interim Analysis of the German DSMM XIa Trial

Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS

Analysing Circulating CD34+ Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities

CHOP Improves Response Rates but Not Overall Survival in Follicular and Mantle Cell Lymphoma (MCL)- Results of a Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG ).

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free Survival in Mantle Cell Lymphoma - Long Term Follow up of a Prospective Randomized Trial of the European MCL Network .

Sequential Cytogenetic Analysis of 322 Patients with Myelodysplastic Syndromes. Delineation of Genetic Evolution and Clinical Implications.

R399H Mutated ETS Domain Leads to a Functional ETV6 Double-Knock-Out in Acute Leukemia and Completely Alters the Physiological Function of ETV6.

Combined Immuno-Chemotherapy (R-CHOP) Results in Significantly Superior Response Rates and Time to Treatment Failure in First Line Treatment of Patients with Lymphomplasmocytoid/ic Immunocytoma (LP-IC) - Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only